PharmaDossierIndependent biopharma information, guidance, and source-cited analysis.

PHARMApharmadossier

Topic

IVIG

Intravenous immunoglobulin coverage, Octagam FDA label, buy-and-bill mechanics, and site-of-care diversion policy.

1 article·Lives underSpecialty Pricing & Access·Last updated 2026-08-10

Specialty· August 10, 2026 · 19 min read

Dermatomyositis Treatment Access (2026): Brepocitinib, Octagam IVIG, and DMARDs

By Ran Chen#Dermatomyositis #Specialty Pharmacy #Payer Policy